Michael S. Mulvihill

A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies

Johannes R. Kratz, Jianxing He, Stephen K. Van Den Eeden et al. · The Lancet · 2012 · 331 citations

Medicine, Molecular Biology, Oncology +15

Long-term outcomes after lobectomy for non–small cell lung cancer when unsuspected pN2 disease is found: A National Cancer Data Base analysis

Chi-Fu Jeffrey Yang, Arvind Kumar, Brian C. Gulack et al. · Journal of Thoracic and Cardiovascular Surgery · 2015 · 87 citations · Full text

Medicine, Oncology, Surgery +14

Pretransplant Desensitization with Costimulation Blockade and Proteasome Inhibitor Reduces DSA and Delays Antibody-Mediated Rejection in Highly Sensitized Nonhuman Primate Kidney Transplant Recipients

Brian Ezekian, Paul M. Schroder, Michael S. Mulvihill et al. · Journal of the American Society of Nephrology · 2019 · 65 citations · Full text

Life Sciences, Immunology, Pharmacology +17

A national analysis of wedge resection versus stereotactic body radiation therapy for stage IA non–small cell lung cancer

Babatunde A. Yerokun, Chi‐Fu Jeffrey Yang, Brian C. Gulack et al. · Journal of Thoracic and Cardiovascular Surgery · 2017 · 61 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Gremlin is Overexpressed in Lung Adenocarcinoma and Increases Cell Growth and Proliferation in Normal Lung Cells

Michael S. Mulvihill, Yong-Won Kwon, Sharon Lee et al. · PLoS ONE · 2012 · 59 citations · Full text

Medicine, Molecular Biology, Oncology +17